Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

BACKGROUND: In the ANRS EASIER trial where treatment-experienced patients switched from enfuvirtide (ENF) to raltegravir (RAL), a high incidence of transaminase elevation was reported in the RAL arm. METHODS: We compared the incidence of emergent liver enzyme elevations (LEE) of grade 2 or more amon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Ther
Main Authors: de Castro, Nathalie, Braun, Joséphine, Charreau, Isabelle, Lafeuillade, Alain, Viard, Jean-Paul, Allavena, Clotilde, Aboulker, Jean-Pierre, Molina, Jean-Michel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818923/
https://ncbi.nlm.nih.gov/pubmed/27042193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-016-0101-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados